The global Extended Release Drug market size in 2023 is XX million US dollars, and it is expected to be XX million US dollars by 2030, with a compound annual growth rate of XX% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Extended Release Drug market include Pfizer, Mallinckrodt, Teva, Johnson & Johnson, and Endo Pharmaceuticals. The share of the top 3 players in the Extended Release Drug market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Extended Release Drug market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Sustained Release Drug accounted for XX% of Extended Release Drug market in 2023. Controlled Release Drug share of XX%.
Hospital Pharmacy accounted for XX% of the Extended Release Drug market in 2023. Retail Pharmacy accounts for XX%.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Extended Release Drug Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.

Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
 
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Extended Release Drug industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Extended Release Drug market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and expansion in recent years.
Chapters 4-6: Segmented the global Extended Release Drug market by type, application and region. Analyze the revenue, sales and price of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, South America and Middle East & Africa Extended Release Drug market country segmentation data and SWOT analysis.
Chapter 12: Analyzes the Extended Release Drug industry chain, including marketing channels, distributors and major downstream buyers.
Chapter 13: Analyzes the Extended Release Drug manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.
Chapter 14: The main points and conclusions of the report.
Chapter 15: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa

Player list
Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries

Types list
Sustained Release Drug
Controlled Release Drug

Application list
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Table of Content

1 Market Overview
1.1 Extended Release Drug Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Extended Release Drug Market Size & Forecast
1.4.1 Global Extended Release Drug Revenue in Value (2019-2030)
1.4.2 Global Extended Release Drug Sales in Volume (2019-2030)
1.4.3 Global Extended Release Drug Price (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Extended Release Drug Market Drivers
1.5.2 Extended Release Drug Market Restraints
1.5.3 Extended Release Drug Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Pfizer SWOT Analysis
2.1.3 Pfizer Extended Release Drug Products and Service Offered
2.1.4 Pfizer Extended Release Drug Sales, Price, Revenue and Gross Margin
2.2 Mallinckrodt
2.2.1 Business Overview
2.2.2 Mallinckrodt SWOT Analysis
2.2.3 Mallinckrodt Extended Release Drug Products and Service Offered
2.2.4 Mallinckrodt Extended Release Drug Sales, Price, Revenue and Gross Margin
2.3 Teva
2.3.1 Business Overview
2.3.2 Teva SWOT Analysis
2.3.3 Teva Extended Release Drug Products and Service Offered
2.3.4 Teva Extended Release Drug Sales, Price, Revenue and Gross Margin
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Johnson & Johnson SWOT Analysis
2.4.3 Johnson & Johnson Extended Release Drug Products and Service Offered
2.4.4 Johnson & Johnson Extended Release Drug Sales, Price, Revenue and Gross Margin
2.5 Endo Pharmaceuticals
2.5.1 Business Overview
2.5.2 Endo Pharmaceuticals SWOT Analysis
2.5.3 Endo Pharmaceuticals Extended Release Drug Products and Service Offered
2.5.4 Endo Pharmaceuticals Extended Release Drug Sales, Price, Revenue and Gross Margin
2.6 Purdue Pharma
2.6.1 Business Overview
2.6.2 Purdue Pharma SWOT Analysis
2.6.3 Purdue Pharma Extended Release Drug Products and Service Offered
2.6.4 Purdue Pharma Extended Release Drug Sales, Price, Revenue and Gross Margin
2.7 Mylan
2.7.1 Business Overview
2.7.2 Mylan SWOT Analysis
2.7.3 Mylan Extended Release Drug Products and Service Offered
2.7.4 Mylan Extended Release Drug Sales, Price, Revenue and Gross Margin
2.8 Hisamitsu Pharmaceutical
2.8.1 Business Overview
2.8.2 Hisamitsu Pharmaceutical SWOT Analysis
2.8.3 Hisamitsu Pharmaceutical Extended Release Drug Products and Service Offered
2.8.4 Hisamitsu Pharmaceutical Extended Release Drug Sales, Price, Revenue and Gross Margin
2.9 Sun Pharmaceutical Industries
2.9.1 Business Overview
2.9.2 Sun Pharmaceutical Industries SWOT Analysis
2.9.3 Sun Pharmaceutical Industries Extended Release Drug Products and Service Offered
2.9.4 Sun Pharmaceutical Industries Extended Release Drug Sales, Price, Revenue and Gross Margin
3 Global Extended Release Drug Market Competition, by Manufacturer
3.1 Global Extended Release Drug Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Extended Release Drug Players Market Share in 2023
3.2.2 Top 6 Extended Release Drug Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Extended Release Drug Players Head Office, Business Provided
3.4 Extended Release Drug Mergers & Acquisitions
3.5 Extended Release Drug New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Extended Release Drug Revenue in Value by Type (2019-2030)
4.2 Global Extended Release Drug Sales in Volume by Type (2019-2030)
4.3 Global Extended Release Drug Revenue in Price by Type (2019-2030)
5 Market Segment by Application
5.1 Global Extended Release Drug Sales in Volume by Application (2019-2030)
5.2 Global Extended Release Drug Revenue by Application (2019-2030)
5.3 Global Extended Release Drug Price by Applications (2019-2030)
6 Global Extended Release Drug Market Analysis by Regions
6.1 Global Extended Release Drug Sales, Revenue and Market Share by Regions
6.1.1 Global Extended Release Drug Revenue by Regions (2019-2030)
6.1.2 Global Extended Release Drug Sales Volume by Regions (2019-2030)
6.2 North America Extended Release Drug Revenue and Growth (2019-2030)
6.3 Europe Extended Release Drug Revenue and Growth (2019-2030)
6.4 Asia Pacific Extended Release Drug Revenue and Growth (2019-2030)
6.5 South America Extended Release Drug Revenue and Growth (2019-2030)
6.6 Middle East and Africa Extended Release Drug Revenue and Growth (2019-2030)
7 North America Extended Release Drug by Country, by Type, and by Application
7.1 North America Extended Release Drug Revenue by Type (2019-2030)
7.2 North America Extended Release Drug Revenue by Application (2019-2030)
7.3 North America Extended Release Drug Revenue, Sales and Market Share by Countries
7.3.1 North America Extended Release Drug Revenue in Value by Country (2019-2030)
7.3.2 North America Extended Release Drug Sales by Country (2019-2030)
7.3.3 United States Extended Release Drug Revenue and Growth (2019-2030)
7.3.4 Canada Extended Release Drug Revenue and Growth (2019-2030)
7.3.5 Mexico Extended Release Drug Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Extended Release Drug by Country, by Type, and by Application
8.1 Europe Extended Release Drug Revenue by Type (2019-2030)
8.2 Europe Extended Release Drug Revenue by Application (2019-2030)
8.3 Europe Extended Release Drug Revenue, Sales and Market Share by Countries
8.3.1 Europe Extended Release Drug Revenue in Value by Country (2019-2030)
8.3.2 Europe Extended Release Drug Sales by Country (2019-2030)
8.3.3 Germany Extended Release Drug Revenue and Growth (2019-2030)
8.3.4 France Extended Release Drug Revenue and Growth (2019-2030)
8.3.5 United Kingdom Extended Release Drug Revenue and Growth (2019-2030)
8.3.6 Russia Extended Release Drug Revenue and Growth (2019-2030)
8.3.7 Italy Extended Release Drug Revenue and Growth (2019-2030)
8.3.8 Nordic Extended Release Drug Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Extended Release Drug by Country, by Type, and by Application
9.1 Asia Pacific Extended Release Drug Revenue by Type (2019-2030)
9.2 Asia Pacific Extended Release Drug Revenue by Application (2019-2030)
9.3 Asia Pacific Extended Release Drug Revenue, Sales and Market Share by Countries
9.3.1 Asia Pacific Extended Release Drug Revenue in Value by Country (2019-2030)
9.3.2 Asia Pacific Extended Release Drug Sales by Country (2019-2030)
9.3.3 China Extended Release Drug Revenue and Growth (2019-2030)
9.3.4 Japan Extended Release Drug Revenue and Growth (2019-2030)
9.3.5 Korea Extended Release Drug Revenue and Growth (2019-2030)
9.3.6 India Extended Release Drug Revenue and Growth (2019-2030)
9.3.7 Southeast Asia Extended Release Drug Revenue and Growth (2019-2030)
9.3.8 Australia Extended Release Drug Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Extended Release Drug by Country, by Type, and by Application
10.1 South America Extended Release Drug Revenue by Type (2019-2030)
10.2 South America Extended Release Drug Revenue by Application (2019-2030)
10.3 South America Extended Release Drug Revenue, Sales and Market Share by Countries
10.3.1 South America Extended Release Drug Revenue in Value by Country (2019-2030)
10.3.2 South America Extended Release Drug Sales by Country (2019-2030)
10.3.3 Brazil Extended Release Drug Revenue and Growth (2019-2030)
10.3.4 Argentina Extended Release Drug Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Extended Release Drug by Country, by Type, and by Application
11.1 Middle East & Africa Extended Release Drug Revenue by Type (2019-2030)
11.2 Middle East & Africa Extended Release Drug Revenue by Application (2019-2030)
11.3 Middle East & Africa Extended Release Drug Revenue, Sales and Market Share by Countries
11.3.1 Middle East & Africa Extended Release Drug Revenue in Value by Country (2019-2030)
11.3.2 Middle East & Africa Extended Release Drug Sales by Country (2019-2030)
11.3.3 Turkey Extended Release Drug Revenue and Growth (2019-2030)
11.3.4 Egypt Extended Release Drug Revenue and Growth (2019-2030)
11.3.5 Saudi Arabia Extended Release Drug Revenue and Growth (2019-2030)
11.3.6 UAE Extended Release Drug Revenue and Growth (2019-2030)
11.3.7 South Africa Extended Release Drug Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Marketing Channel, Distributors, Traders and Dealers
12.1 Marketing Channel Status
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Extended Release Drug Typical Distributors
12.3 Extended Release Drug Typical Customers
12.4 Consumer Behavior Analysis
13 Extended Release Drug Manufacturing Cost Analysis
13.1 Extended Release Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Extended Release Drug
13.4 Extended Release Drug Industrial Chain Analysis
14 Research Findings and Conclusion
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer

List of Tables and Figures

Figure Extended Release Drug Picture
Table Product Specifications of Extended Release Drug
Figure Global Revenue Market Share of Extended Release Drug by Types in 2023
Table Types of Extended Release Drug
Figure Extended Release Drug Market Share by Applications in 2023
Table Application of Extended Release Drug
Figure Global Extended Release Drug Revenue in Value (2019-2030)
Figure Global Extended Release Drug Sales in Volume (2019-2030)
Table Global Extended Release Drug Price (2019-2030)
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Pfizer Details
Table SWOT Analysis
Table Pfizer Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Pfizer Revenue Market Share 2019-2024
Table Mallinckrodt Details
Table SWOT Analysis
Table Mallinckrodt Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Mallinckrodt Revenue Market Share 2019-2024
Table Teva Details
Table SWOT Analysis
Table Teva Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Teva Revenue Market Share 2019-2024
Table Johnson & Johnson Details
Table SWOT Analysis
Table Johnson & Johnson Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Johnson & Johnson Revenue Market Share 2019-2024
Table Endo Pharmaceuticals Details
Table SWOT Analysis
Table Endo Pharmaceuticals Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Endo Pharmaceuticals Revenue Market Share 2019-2024
Table Purdue Pharma Details
Table SWOT Analysis
Table Purdue Pharma Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Purdue Pharma Revenue Market Share 2019-2024
Table Mylan Details
Table SWOT Analysis
Table Mylan Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Mylan Revenue Market Share 2019-2024
Table Hisamitsu Pharmaceutical Details
Table SWOT Analysis
Table Hisamitsu Pharmaceutical Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Hisamitsu Pharmaceutical Revenue Market Share 2019-2024
Table Sun Pharmaceutical Industries Details
Table SWOT Analysis
Table Sun Pharmaceutical Industries Extended Release Drug Sales, Price, Revenue and Gross Margin (2019-2024)
Figure Sun Pharmaceutical Industries Revenue Market Share 2019-2024
Table Global Extended Release Drug Revenue by Manufacturer (2019-2024)
Figure Global Extended Release Drug Revenue Market Share by Manufacturer in 2023
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global Extended Release Drug Manufacturers Market Concentration Ratio (CR5) (2019-2024)
Table Extended Release Drug Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Global Extended Release Drug Revenue in Value by Type (2019-2030)
Table Global Extended Release Drug Revenue Share by Type (2019-2030)
Table Global Extended Release Drug Sales in Volume by Type (2019-2030)
Table Global Extended Release Drug Sales Share by Type (2019-2030)
Table Global Extended Release Drug Revenue in Price by Type (2019-2030)
Table Global Extended Release Drug Sales in Volume by Application (2019-2030)
Table Global Extended Release Drug Sales Share by Application (2019-2030)
Table Global Extended Release Drug Revenue by Application (2019-2030)
Table Global Extended Release Drug Revenue Share by Application (2019-2030)
Table Global Extended Release Drug Price by Applications (2019-2030)
Figure Global Extended Release Drug Sales in Volume and Growth (2019-2030)
Figure Global Extended Release Drug Revenue and Growth (2019-2030)
Table Global Extended Release Drug Revenue by Regions (2019-2030)
Table Global Extended Release Drug Revenue Market Share by Regions (2019-2030)
Table Global Extended Release Drug Sales Volume by Regions (2019-2030)
Table Global Extended Release Drug Sales Volume Market Share by Regions (2019-2030)
Figure North America Extended Release Drug Revenue and Growth (2019-2030)
Figure Europe Extended Release Drug Revenue and Growth (2019-2030)
Figure Asia Pacific Extended Release Drug Revenue and Growth (2019-2030)
Figure South America Extended Release Drug Revenue and Growth (2019-2030)
Figure Middle East and Africa Extended Release Drug Revenue and Growth (2019-2030)
Table North America Extended Release Drug Revenue by Type (2019-2030)
Table North America Extended Release Drug Revenue by Application (2019-2030)
Table North America Extended Release Drug Revenue by Countries (2019-2030)
Table North America Extended Release Drug Revenue Market Share by Countries (2019-2030)
Table North America Extended Release Drug Sales in Volume by Countries (2019-2030)
Table North America Extended Release Drug Sales Market Share by Countries (2019-2030)
Figure United States Extended Release Drug Revenue and Growth (2019-2030)
Figure Canada Extended Release Drug Revenue and Growth (2019-2030)
Figure Mexico Extended Release Drug Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Europe Extended Release Drug Revenue by Type (2019-2030)
Table Europe Extended Release Drug Revenue by Application (2019-2030)
Table Europe Extended Release Drug Revenue by Countries (2019-2030)
Table Europe Extended Release Drug Revenue Market Share by Countries (2019-2030)
Table Europe Extended Release Drug Sales in Volume by Countries (2019-2030)
Table Europe Extended Release Drug Sales Market Share by Countries (2019-2030)
Figure Germany Extended Release Drug Revenue and Growth (2019-2030)
Figure France Extended Release Drug Revenue and Growth (2019-2030)
Figure United Kingdom Extended Release Drug Revenue and Growth (2019-2030)
Figure Russia Extended Release Drug Revenue and Growth (2019-2030)
Figure Italy Extended Release Drug Revenue and Growth (2019-2030)
Figure Nordic Extended Release Drug Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Asia Pacific Extended Release Drug Revenue by Type (2019-2030)
Table Asia Pacific Extended Release Drug Revenue by Application (2019-2030)
Table Asia Pacific Extended Release Drug Revenue by Countries (2019-2030)
Table Asia Pacific Extended Release Drug Revenue Market Share by Countries (2019-2030)
Table Asia Pacific Extended Release Drug Sales in Volume by Countries (2019-2030)
Table Asia Pacific Extended Release Drug Sales Market Share by Countries (2019-2030)
Figure China Extended Release Drug Revenue and Growth (2019-2030)
Figure Japan Extended Release Drug Revenue and Growth (2019-2030)
Figure Korea Extended Release Drug Revenue and Growth (2019-2030)
Figure India Extended Release Drug Revenue and Growth (2019-2030)
Figure Southeast Asia Extended Release Drug Revenue and Growth (2019-2030)
Figure Australia Extended Release Drug Revenue and Growth (2019-2030)
Table SWOT Analysis
Table South America Extended Release Drug Revenue by Type (2019-2030)
Table South America Extended Release Drug Revenue by Application (2019-2030)
Table South America Extended Release Drug Revenue by Countries (2019-2030)
Table South America Extended Release Drug Revenue Market Share by Countries (2019-2030)
Table South America Extended Release Drug Sales in Volume by Countries (2019-2030)
Table South America Extended Release Drug Sales Market Share by Countries (2019-2030)
Figure Brazil Extended Release Drug Revenue and Growth (2019-2030)
Figure Argentina Extended Release Drug Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Middle East & Africa Extended Release Drug Revenue by Type (2019-2030)
Table Middle East & Africa Extended Release Drug Revenue by Application (2019-2030)
Table Middle East & Africa Extended Release Drug Revenue by Countries (2019-2030)
Table Middle East & Africa Extended Release Drug Revenue Market Share by Countries (2019-2030)
Table Middle East & Africa Extended Release Drug Sales in Volume by Countries (2019-2030)
Table Middle East & Africa Extended Release Drug Sales Market Share by Countries (2019-2030)
Figure Turkey Extended Release Drug Revenue and Growth (2019-2030)
Figure Egypt Extended Release Drug Revenue and Growth (2019-2030)
Figure Saudi Arabia Extended Release Drug Revenue and Growth (2019-2030)
Figure UAE Extended Release Drug Revenue and Growth (2019-2030)
Figure South Africa Extended Release Drug Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Distributors of Extended Release Drug with Contact Information
Table Major Customers of Extended Release Drug with Contact Information
Table Consumer Behavior Analysis
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Table Raw Materials Analysis
Table Labor Cost Analysis
Table Manufacturing Expenses Analysis
Table Manufacturing Process Analysis of Extended Release DrugAnalysis
Figure Extended Release Drug Industrial Chain Analysis
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report